Science ❯ Biotechnology

Gene Editing

CRISPR Technology Gene Therapy CRISPR Therapeutic Applications CRISPR/Cas9 CRISPR-Cas9 Xenotransplants Base Editing Therapeutic Gene Editing Xenotransplantation Adeno-Associated Virus In Vivo Therapy Therapeutics AI in Medicine Chimeric Antigen Receptor Therapy Therapeutic Technologies CRISPR Applications Crops Xenotransplantation Research CRISPR Therapeutics Crispr Technology Animal Genomes

EU Strikes Provisional Deal to Ease Rules for Gene-Edited Crops

The draft creates a two-tier system that exempts many simple edits from GMO rules, pending second-reading approval.

CRISPR-Edited Fungus Boosts Mycoprotein Efficiency, Cuts Modeled Emissions

FDA Outlines 'Plausible-Mechanism' Pathway to Speed Bespoke Therapies

Intellia Pauses Phase 3 Trials of CRISPR Therapy After Severe Liver Event

Lilly to Buy Adverum in Gene‑Therapy Deal Worth Up to $12.47 a Share

Antibody Blocking SLAMF6 Restores T-Cell Attack on AML in Preclinical Study

Nature Papers Identify RHOG and CDKN1B as In Vivo Boosters for CAR T Cells

Kite Pharma to Buy Interius for $350 Million, Adding In‑Vivo CAR‑T Platform

Kidney Organoids Reveal NFκB‑Linked AAV2 Toxicity, With Bardoxolone Methyl Mitigating Damage

Prime Editing Reverses Rare Childhood Brain Disorder by Correcting Multiple Mutations in Mice

Single CRISPR Treatment Lets Mice Produce Weight-Loss Drug for Over Six Months

Personalized CRISPR Therapy Sends Baby KJ Home from CHOP

Next-Generation CAR-T Therapies Deliver Remission in T-Cell Cancers and Extend Survival in Gastric and Brain Tumors